Breakthrough ALS study launches as drug aims to slow disease progression
Friday, April 3rd 2026, 11:00:47 am
article
An ALS drug trial testing pridopidine has entered phase 3 of the one-of-a-kind PREVAiLS study, aiming to slow disease progression in early-stage patients.
Breaking
Bitcoin continued to trade near the $67,000 level just following the strong report....
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero...
